These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6982786)

  • 1. Adenosine and deoxyadenosine toxicity in colony assay systems for human T-lymphocytes, B-lymphocytes, and granulocytes.
    Brox LW; Pollock E; Belch A
    Cancer Chemother Pharmacol; 1982; 9(1):49-52. PubMed ID: 6982786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
    Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
    Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin.
    Brox L; Ng A; Pollock E; Belch A
    Cancer Res; 1984 Mar; 44(3):934-7. PubMed ID: 6607110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 3H-thymidine incorporation by adenosine and deoxyadenosine in human peripheral lymphocytes and malignant lymphoid cell lines.
    van der Krann PM; van Zandvoort PM; De Abreu RA; Bakkeren JA; van Laarhoven JP; de Bruijn CH
    Adv Exp Med Biol; 1986; 195 Pt B():213-9. PubMed ID: 3490120
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
    Tanaka M; Kimura K
    Tohoku J Exp Med; 1985 Dec; 147(4):331-41. PubMed ID: 3879563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.
    Matsumoto SS; Yu J; Yu AL
    J Immunol; 1983 Dec; 131(6):2762-6. PubMed ID: 6196398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 2'-deoxycoformycin on erythroid, granulocytic, and T-lymphocyte colony growth.
    Aye MT; Dunne JV
    Blood; 1981 Nov; 58(5):1043-6. PubMed ID: 6975136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
    Kang GJ; Kimball AP
    Cancer Res; 1984 Feb; 44(2):461-6. PubMed ID: 6362851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus deoxycoformycin.
    Matsumoto SS; Yu AL; Yu J
    Cancer Invest; 1985; 3(3):225-33. PubMed ID: 3873981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative sensitivity of peripheral blood T-lymphocyte colony forming cells and bone marrow CFU-GM to deoxyadenosine and 2'deoxycoformycin.
    Russell NH; Carron J; Hoffbrand AV; Bellingham AJ
    Leuk Res; 1985; 9(2):315-9. PubMed ID: 3872974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
    Seto S; Carrera CJ; Kubota M; Wasson DB; Carson DA
    J Clin Invest; 1985 Feb; 75(2):377-83. PubMed ID: 2579098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in L1210 and P388 mouse leukemia cells.
    Plagemann PG; Wohlhueter RM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6418-24. PubMed ID: 3877568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
    Bagnara AS; Hershfield MS
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
    Kefford RF; Fox RM
    Br J Haematol; 1982 Apr; 50(4):627-36. PubMed ID: 6978147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the effect of deoxyadenosine on deoxycoformycin-treated myeloid and lymphoid stem cells.
    Aye MT; Dunne JV; Yang WC
    Blood; 1982 Oct; 60(4):872-6. PubMed ID: 6981441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical studies on deoxycoformycin and deoxyadenosine as pharmacologic T cell purging tools.
    Sheridan W; Gordon DS; Fullen AJ; Olson A; Vogler WR; Winton E
    Bone Marrow Transplant; 1989 Sep; 4(5):511-7. PubMed ID: 2790329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD; Ip H; Pereira S
    Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin.
    Schwartz CL; Minniti CP; Harwood P; Na S; Banquerigo ML; Strauss LC; Kurtzberg J; Smith SD; Civin CI
    J Clin Oncol; 1987 Dec; 5(12):1900-11. PubMed ID: 3500279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.